Need for differential discounting of costs and health effects in cost effectiveness analyses -- Brouwer et al. 331 (7514): 446 -- BMJ

Need for differential discounting of costs and health effects in cost effectiveness analyses -- Brouwer et al. 331 (7514): 446 -- BMJ: "Discounting can have a strong influence on cost effectiveness ratios for priority setting, especially in preventive interventions. It is therefore crucial that appropriate discount rates are used in economic evaluations. Increasingly, it is argued that the rate for future non-monetary health effects should be below that for future costs, to account for the growing value of health effects. The previous guidelines of the National Institute for Health and Clinical Excellence (NICE) on economic evaluation were the first national guidelines to prescribe such differential discounting (6% for costs and 1.5% for effects). However, in its latest guidelines both rates are set at 3.5%, implying a lower weight for future effects.1 We argue that this change is not based on contemporary health economic literature nor convincingly justified."